Sign in
4/A

Changes in Ownership

Viridian Therapeutics, Inc.DE Filed Acc 0001193125-26-099023

Chief Financial Officer gave up 2,031 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Harmon Seth · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Shares withheld for taxes : show line 1 in the form −2,031 $30.19 $61,316 7,850 D
Loading xslF345X05/ownership.xml…